Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The study is to determine the safety and efficacy of Dutasteride in patients who have failed
Finasteride therapy for their symptomatic benign prostatic enlargement/ hypertrophy (BPE/H).
Phase:
N/A
Details
Lead Sponsor:
North Florida/South Georgia Veterans Health System